Re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. 2026;89:114–120

View at publisher
Authors: Harry Herr
Cited by: 0
References: 6

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Immunotherapy and Immune Responses Urinary Tract Infections Management

Publication details

Journal / source
European Urology
Volume
89
Issue
6
Pages
e144–e144
Publication date
12 January 2026
Language
EN